Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.83

€2.83

1.800%
0.05
1.800%
-

-

 
08:00 / Tradegate WKN: A1JPJY / Symbol: CLVS / Name: Clovis Oncology / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
21.12.20
-34.81%
buy
Your prediction

Clovis Oncology Inc. Stock

Clovis Oncology Inc. gained 1.800% today.
The community is currently still undecided about Clovis Oncology Inc. with 1 Buy predictions and 0 Sell predictions.
So far the community has only identified positive things for Clovis Oncology Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Clovis Oncology Inc. in the next few years

Pros
2
Could be worthwhile Investment >10% per year
1
Small cyclical dependencies
1
Known brand
Cons
0
-

Performance of Clovis Oncology Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Clovis Oncology Inc. 1.800% -4.692% -25.628% -32.320% -23.649% -81.533% -91.766%
Champions Oncology Inc 3.870% -13.636% -9.524% -15.556% -16.022% - -
Aveo Pharmaceuticals Inc. -1.250% -1.852% -5.438% 25.056% 24.636% -69.590% -9.365%
Epizyme Inc. -3.170% -6.869% -23.779% -75.103% -70.073% - -

Comments

Buy Clovis Oncology Inc.
Show more

Other discussions about Clovis Oncology Inc. Stock

New thread Forum

News

Clovis Oncology Announces Third Quarter 2021 Operating Results: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology Announces Third Quarter 2021 Operating Results


Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended September 30, 2021, and provided an update on the Company’s clinical development programs and regulatory and

Clovis Oncology to Announce Third Quarter 2021 Financial Results and Host Webcast Conference Call on November 3: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology to Announce Third Quarter 2021 Financial Results and Host Webcast Conference Call on November 3


Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its third quarter 2021 financial results on Wednesday, November 3, 2021, before the open of the US financial markets. Clovis’ senior management

Clovis Oncology and ITM Announce Lutetium-177 Clinical Supply Agreement: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology and ITM Announce Lutetium-177 Clinical Supply Agreement


Clovis Oncology, Inc. (NASDAQ: CLVS) and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, today announced the signing of a clinical supply agreement that provides